Admach Systems reported a strong H1 FY27 with revenue up 48.34% to INR 42.2 crore and PAT rising 45.91% to INR 6.53 crore. The company maintains a 23% EBITDA margin, supported by strategic in-house manufacturing. With an order book of INR 77.42 crore and aggressive expansion plans in the nuclear and defense sectors, management expects full-year revenue to surpass INR 100 crore.
Admach Systems Reports Strong H1 FY27 Growth
Revenue: INR 42.2 crore (Up 48.34% YoY); PAT: INR 6.53 crore (Up 45.91% YoY).
Reader Takeaway: Strong operational margins driven by in-house production, though watch for extended lead times on government project contracts.
What just happened
Admach Systems has delivered robust financial results for the first half of FY27. The company's focus on vertical integration—specifically bringing component manufacturing in-house—has successfully defended a sustainable 23% EBITDA margin. Revenue reached INR 42.2 crore, signaling significant scaling during the period.
Why this matters
The company is positioning itself as a key player in import substitution, with two new products slated for launch within 3.5 months targeting the steel and nuclear sectors. Additionally, management is tapping into global demand as European partners increasingly look to India to mitigate their regional energy and operational cost pressures.
Order Book and Execution
The current order book stands at INR 77.42 crore. Management expects to execute between INR 65 crore and INR 70 crore of this backlog by the end of the current fiscal year. The nuclear and defense segments, while currently accounting for 4-5% of the total order book, are identified as primary growth levers for the future.
Management Commentary and Guidance
Management remains bullish, providing a guidance that total revenue for FY27 will cross the INR 100 crore milestone. To support this growth, a capital expenditure of INR 15-16 crore is planned for the year, with 60% dedicated to machinery upgrades and 40% to facility infrastructure.
Risks to watch
Investors should note the inherent timelines associated with government and nuclear sector contracts. Management acknowledged that these projects typically require two quarters to transition from the bidding stage into the active commercial execution zone, which may lead to periodic fluctuations in quarterly reporting.
What to track next
Watch for the commercial launch of the two new import-substitute products and the company's ability to maintain its 23% EBITDA margin as it scales production through the new capital investment cycle.
